Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Interest Expenses (2016 - 2026)

Pediatrix Medical (MD) has disclosed Interest Expenses for 17 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 9.99% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.0 million through Dec 2025, down 11.73% year-over-year, with the annual reading at $36.0 million for FY2025, 11.73% down from the prior year.
  • Interest Expenses for Q4 2025 was $8.7 million at Pediatrix Medical, down from $8.9 million in the prior quarter.
  • The five-year high for Interest Expenses was $17.6 million in Q1 2021, with the low at $8.4 million in Q2 2022.
  • Average Interest Expenses over 5 years is $11.4 million, with a median of $10.2 million recorded in 2024.
  • The sharpest move saw Interest Expenses tumbled 50.18% in 2022, then skyrocketed 33.55% in 2023.
  • Over 5 years, Interest Expenses stood at $16.6 million in 2021, then crashed by 40.06% to $10.0 million in 2022, then rose by 1.3% to $10.1 million in 2023, then fell by 3.68% to $9.7 million in 2024, then decreased by 9.99% to $8.7 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $8.7 million, $8.9 million, and $9.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.